Loading clinical trials...
Loading clinical trials...
The Clinical Applications of Multiplex Analysis of Circulating Tumor DNA Biomarkers in Lung Cancer Patients
Conditions
Locations
1
China
Peking University People's Hospital
Beijing, Beijing Municipality, China
Start Date
April 11, 2019
Primary Completion Date
June 1, 2020
Completion Date
June 1, 2022
Last Updated
February 5, 2020
NCT05673200
NCT04929028
NCT03647358
NCT05372640
NCT04704661
NCT05691465
Lead Sponsor
Peking University People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions